Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
Липосомы, реагирующие на стимулы, как интеллектуальные наноплатформы для доставки лекарственных средств
2017-10-10
SCID: 54.1/jnhatbej
Discuss with AI
active targetingdrug deliverysmart nanoplatformsstimuli-responsive drug releasestimulus-responsive liposomes
Figures from the paper
Abstract (AI)
Liposomes are known to be promising nanoparticles (NPs) for drug delivery applications. Among different types of self-assembled NPs, liposomes stand out for their non-toxic nature, and their possession of dual hydrophilic-hydrophobic domains. Advantages of liposomes include the ability to solubilize hydrophobic drugs, the ability to incorporate different hydrophilic and lipophilic drugs at the same time, lessening the exposure of host organs to potentially toxic drugs and allowing modification of the surface by a variety of different chemical groups. This modification of the surface, or of the individual constituents, may be used to achieve two important goals. Firstly, ligands for active targeting can be attached that are recognized by cognate receptors over-expressed on the target cells of tissues. Secondly, modification can be used to impart a stimulus-responsive or "smart" character to the liposomes, whereby the cargo is released on demand only when certain internal stimuli (pH, reducing agents, specific enzymes) or external stimuli (light, magnetic field or ultrasound) are present. Here, we review the field of smart liposomes for drug delivery applications.
Key Findings
1
External stimuli including light, magnetic fields, and ultrasound can also trigger drug release from smart liposomes.
2
Liposome surface modification can reduce exposure of host organs to potentially toxic drugs and support attachment of active-targeting ligands.
3
Liposomes are promising drug-delivery nanoparticles because they are non-toxic and contain both hydrophilic and hydrophobic domains.
4
Stimulus-responsive modifications enable on-demand cargo release in response to internal triggers such as pH, reducing agents, and enzymes.
5
Their dual-domain architecture enables simultaneous incorporation of hydrophilic and lipophilic drugs and solubilization of hydrophobic compounds.
Research Object
stimulus-responsive liposomes used as drug delivery nanoplatforms
Research Subject
stimulus-triggered on-demand drug release from liposomes in response to internal or external stimuli
Publication Details
Publication Date
2017-10-10
Journal
Publisher
ISSN
Cited by
163
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest